Clinical Trial Update: A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites [Phase 1]

View source ↗

Summary

Phase 1 tolerance study evaluating intraperitoneal perfusion of Cinobufacini Injection in digestive system cancers with malignant ascites; current status is unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Neoplasms
• Malignant Ascites

Drugs mentioned

• Cinobufacini Injection (cinobufacini)

Snippet

Sponsor: Dongfang Hospital Beijing University of Chinese Medicine | Conditions: Digestive System Cancer, Malignant Ascites | Phase 1 | Status: UNKNOWN